Is Melanotan-2 Legal in Australia? (2026)
A factual look at how Australia's Therapeutic Goods Administration treats Melanotan-2 (melanotan II), including its scheduling, its absence from the ARTG, and how it differs from the approved therapeutic good afamelanotide. General information only, not legal or medical advice.
The short answer
Melanotan-2 (also written as melanotan II or MT-2) is not an approved therapeutic good in Australia. It is a scheduled substance under the Poisons Standard, it is not listed on the Australian Register of Therapeutic Goods (ARTG), and the Therapeutic Goods Administration (TGA) has issued safety communications about tanning products that contain it.
In practical regulatory terms, Melanotan-2 is treated as a prescription-category substance that has no approved, registered product behind it. There is no over-the-counter pathway, and the TGA has stated it is unlawful to import injectables such as Melanotan-2 for personal use without a prescription from an Australian-registered medical practitioner. NovaPeptides references Melanotan-2 in a research-use-only context only.
This page is general information only, not legal or medical advice. Scheduling and import rules can change. For the definitive position, always check the current Poisons Standard and the TGA website, and seek your own professional advice.
How the TGA classifies Melanotan-2
Substances in Australia are classified through the Poisons Standard, formally the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). Scheduling decisions are made by a delegate of the Secretary of the Department of Health, informed by expert advisory committees.
Melanotan-2 (melanotan II) has been considered through this scheduling process. A delegate's final decision placed melanotan II in Schedule 4 (Prescription Only Medicine). A Schedule 4 listing means the substance is restricted to supply via a prescription from an authorised health practitioner, rather than being freely available.
Scheduling can be reviewed and amended over time. We do not restate a schedule number as permanent. For the current, authoritative classification of melanotan II, consult the latest version of the Poisons Standard on the TGA website.
Not approved and not on the ARTG
Being scheduled is different from being approved. Scheduling describes how a substance is controlled. Approval and registration on the ARTG means a specific product has been assessed by the TGA for quality, safety and efficacy and may be lawfully supplied for its registered purpose.
The TGA has stated that there are no products containing Melanotan-2 included in the ARTG or approved for supply in Australia. In other words, there is no registered Melanotan-2 product. The TGA has also noted that Melanotan-2 products sold informally have not been assessed by the TGA for quality, safety or efficacy.
What the TGA position means
- Melanotan-2 is a scheduled substance, not a freely available product.
- No Melanotan-2 product is registered on the ARTG.
- It is not TGA-approved for any human therapeutic use.
- It is unlawful to import injectables such as Melanotan-2 for personal use without a prescription from an Australian-registered medical practitioner.
The afamelanotide (Scenesse) distinction
Melanotan-2 is frequently confused with afamelanotide, which is a different peptide with a very different regulatory status. This distinction matters, because the two are not interchangeable in law or in science.
Afamelanotide, marketed as Scenesse by Clinuvel Pharmaceuticals, is a registered therapeutic good in Australia. The TGA approved Scenesse for registration on the ARTG, with the decision recorded in late 2020, to prevent phototoxicity in adult patients with erythropoietic protoporphyria (EPP), a rare light-sensitivity condition. It is a prescription medicine administered by trained, accredited healthcare professionals.
Melanotan-2 is a separate compound. It is not afamelanotide, it is not Scenesse, and it does not share Scenesse's ARTG registration or approved indication. When people ask whether Melanotan-2 is legal and point to Scenesse as evidence, they are pointing to a different, approved product.
Afamelanotide (Scenesse) is ARTG-registered for a specific rare condition. Melanotan-2 (melanotan II) is a distinct, unapproved substance. One being approved says nothing about the status of the other.
What research use only means
A research-use-only (RUO) designation describes the intended context of a material. It signals that the item is supplied as a laboratory reference compound for in-vitro or laboratory investigation by qualified researchers, and not as a medicine, supplement, cosmetic or product for human or animal administration.
RUO materials are not assessed, registered or approved as therapeutic goods. A research-use-only label is not an approval, and it is not a claim about safety or efficacy in people. It is a statement about scope. NovaPeptides references Melanotan-2 strictly within this research-use-only framing.
Research use only, in plain terms
- Supplied for laboratory research by qualified parties.
- Not a medicine and not for human or veterinary use.
- Not ARTG-registered and not TGA-approved.
- Not a safety, efficacy or performance claim of any kind.
What Melanotan-2 is (neutral overview)
Melanotan-2 is a synthetic peptide. In scientific terms it is described as a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) and a melanocortin receptor agonist, meaning it is studied for its interaction with the melanocortin family of receptors.
This places it in the broader category of melanocortin-active research peptides. It is structurally and functionally distinct from afamelanotide, despite both being referenced in melanocortin research literature. This section is a neutral description of what the molecule is and does not describe, endorse or instruct any use.
Importation and supply, a factual note
The TGA has publicly stated that it is unlawful to import injectables such as Melanotan-2 into Australia for personal use without a prescription from an Australian-registered medical practitioner. The TGA has also taken enforcement action in connection with the unlawful supply of Melanotan-2 products, including issuing infringement notices.
This is stated here as factual regulatory context, not as guidance. This page does not explain how to obtain, import, supply or use Melanotan-2, and nothing here should be read as encouragement to do so. Anyone considering any activity involving a scheduled substance should obtain their own legal and professional advice.
The information above describes the regulatory landscape. It is not a how-to, and it is not advice. Always refer to current TGA guidance and seek qualified advice.
How NovaPeptides references Melanotan-2
NovaPeptides references Melanotan-2 in a research-use-only context, consistent with its position as an Australian catalogue focused on laboratory reference materials. We do not position Melanotan-2 as a medicine, a tanning product, a supplement or a cosmetic, and we make no therapeutic, efficacy or outcome claims about it.
Where available, research compounds are accompanied by Novagen Certificate of Analysis (COA) documentation to support identity and purity records for laboratory contexts. A COA is an analytical record, not an approval, and it does not change the regulatory status of a substance.
For the authoritative legal position in Australia, the primary sources are the current Poisons Standard and the TGA. This page is intended as a neutral starting point for understanding the landscape, not as a substitute for those sources or for professional advice.
Frequently asked questions
Is Melanotan-2 legal in Australia?+
Melanotan-2 (melanotan II) is a scheduled substance under the Poisons Standard, it is not on the ARTG, and it is not TGA-approved for human use. There is no over-the-counter pathway, and the TGA has stated it is unlawful to import injectables such as Melanotan-2 for personal use without a prescription from an Australian-registered medical practitioner. This is general information only, not legal advice.
Is Melanotan-2 on the ARTG?+
No. The TGA has stated that there are no products containing Melanotan-2 included on the Australian Register of Therapeutic Goods or approved for supply in Australia.
Is Melanotan-2 the same as afamelanotide or Scenesse?+
No. Afamelanotide (Scenesse) is a different, ARTG-registered prescription medicine approved to prevent phototoxicity in adults with erythropoietic protoporphyria. Melanotan-2 is a distinct, unapproved substance and does not share that registration.
What schedule is Melanotan-2 in?+
A delegate's final decision placed melanotan II in Schedule 4 (Prescription Only). Scheduling can be reviewed over time, so check the current Poisons Standard on the TGA website for the definitive, up-to-date classification.
What is Melanotan-2 in scientific terms?+
It is described as a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) and a melanocortin receptor agonist. This is a neutral description of the molecule, not a description of any use.
Is Melanotan-2 banned in sport?+
As an unapproved substance acting on melanocortin receptors, Melanotan-2 may be captured by anti-doping rules, including broad provisions covering substances without current human-use approval. Athletes should confirm the current position directly with WADA and their national anti-doping authority.
Does research use only mean it is approved?+
No. Research use only describes the intended laboratory context of a material. It is not a TGA approval and it is not a safety or efficacy claim.
Questions? Talk to us.
Message us on WhatsApp and we will walk you through the kits, the COAs, reconstitution and the dose tool.
Chat with us on WhatsApp